Marc is the Head of Strategic Venture Capital Fund & Pharma Equities at Novartis Pharma. Before this appointment he held the position of Head of Finance, Global Business Development & Licensing (Novartis Pharma).
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, Novartis uses innovative science and digital technologies to create transformative treatments in areas of great medical need

Jenny helps health tech companies scale and healthcare organisations innovate.
Currently she is supporting Virtual Hospital company “Doccla” as their Director of Implementation and Scale Up. Jenny previously founded and led DigitalHealth.London - now one of the largest brands in digital health. While there she incubated the best health tech start-ups and scale-ups to save the NHS millions and grow to create hundreds of new jobs in the health tech sector. Working in senior roles in the NHS provided her with operational, real-life perspective, and first-hand experience of adopting health tech solutions. Jenny is currently an independent Health Tech advisor and has supported several companies with strategy, growth, fundraising, partnerships, business development, evidence generation, hiring, operations and coaching.

Rajeev has held several positions during his ~15 year tenure at Biomarin, a company specializing in developing therapeutics through genetic discovery.
He is currently the Director of Competitive Intelligence-Product Portfolio Development (CI-PPD). He leads the CI-PPD efforts for the Genetic Short Stature Franchise, Phenylketonuria Franchise, Lysosomal Storage Disease Franchise, and Hyperoxaluria Franchise. He is a member of Franchise Core Teams responsible for developing the indication prioritization, clinical and regulatory, commercialization, and lifecycle management strategies for the pipeline programs.
Prior to the CI-PPD role, Rajeev led the non-clinical development efforts of several pipeline therapeutics at Biomarin, mostly recently the AAV gene therapies for Hemophilia A and Phenylketonuria. Rajeev’s most recent role in Research and Early Development was Principal Scientist, Head of AAV Analytics and Assays.
London Business School SLOAN Fellow 2019-2020

Michael Niddam is the CEO and Co-Founder of Kamet Ventures - a venture inventor and builder focused on creating breakthrough companies that will redefine the sectors of insurtech, healthtech and mobility as we know them today.
Prior to Kamet, Michael was a Partner in the Insurance and TMT practices of Boston Consulting Group (BCG). During his time at BCG, Michael was instrumental in developing BCG’s offering in the digital space and was also involved in the opening of the firm’s offices in Israel. Michael has also launched three successful technology start-ups focused on media and Big Data. He is a graduate of École Polytechnique and ENSAE

Jason has an extensive knowledge of the UK, US and EU healthcare markets and has helped build several organizations that maximize the value of their products & services to improve health and achieve significant returns for investors.
He has assumed a variety of senior roles in the healthcare industry and is currently the Chief Executive Officer and Executive Director at Ori Biotech – a leader in CGT manufacturing technology that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalised, lifesaving treatments.

Rory is the Service Owner of a suite of deep tech products and tools at Genomics England, leading 11 teams to develop ground-breaking products and AI/ML that enable academia, biotech and pharma companies to advance science and enhance drug discovery. Rory also advises Life Science start-ups for leading accelerators and incubators with focus on artificial intelligence and (AI) machine learning (ML) technologies.Formally a strategy consultant with focus on corporate, commercial and deals strategy, he holds a Visiting Professor position at ESCP Europe Business School where he teaches Commercial Strategy and Entrepreneurship.
Rory has founded or co-founded five start-ups, most recently a deep science AI/ML development tech. platform, and a data federation and bioinformatics workflow tech. platform.

Rahul is the director of Health Tech business at CPI, which offers end to end innovation development services. We work with mature companies and start-ups to develop transformative ideas into commercial products.
He has 15+ years of global experience working for Johnson & Johnson and Unilever. At J&J, Rahul led growth of medical devices within cardiovascular across EMEA. He worked on the adoption of innovative mental health and infectious pharmaceutical treatments in the NHS.
Recently, at Medicspot, a digital health company, Rahul has been working as the Chief Commercial Officer. Medicspot is creating digital technologies that will improve access and efficiencies within primary healthcare space so everyone can access the right care at the right time. Rahul worked on building up Arc Health, a digital technology business and helped grow Medicspot's primary healthcare business.
He holds an MBA from London Business School and a Chemical Engineering degree from Indian Institute of Technology, Delhi.

Manish is an Investor, having been involved in venture capital and private equity for nearly two decades, both as an investor and a consultant. He currently invests in and advises early-stage companies and VC funds, as Managing Partner of YNM Growth Capital.
Most recently Manish was a Director at Nesta Impact Investments, working across sectors and leading the Healthy Ageing investment partnership with UKRI. Manish was responsible for Nesta’s investments in Sumdog and MEL Science, and also led various portfolio investments to exits including Futuregov, Q Doctor, BeApplied, Empiribox, Digital Assess, and Synopsis Healthcare.
Prior to Nesta, Manish has worked at Sovereign Capital and Terra Firma Capital, where the investments included Hillcrest (Outcomes First), Eden Futures, WCL, GSM, Astrum, and Lifetime. Manish started his career in marketing at Colgate Palmolive followed by strategy consulting at Accenture. Manish is a Mentor to the NHS Innovation Accelerator and speaker and judge for various investments from InnovateUK (UKRI), GLA, UK DIT, and others.

Sree is Director of finance and strategy of a SaaS business helping UK care businesses meet regulatory and compliance requirements. He has extensive consulting and operational management experience in technology having worked with KPMG and McKinsey and with FTI in turnarounds. He has built the global services unit at Cisco in India and E Europe, grown and successfully exited several tech and SMEs and been a mentor in two accelerators.  
Sree is a chartered accountant and an MBA from London Business School where he founded the Healthcare Club in 1997. Sree has grown and successfully exited several businesses in healthcare, technology, consulting and managed services in Europe, US and India. He has worked with and been funded by leading equity and debt providers such as Morgan Stanley, Texas Pacific, Atlas Venture, JP Morgan Chase, Citi and GE.

Dr. Nayan Kalnad is a clinician by training and has 15+ years experience in digital healthcare and pharma R&D. Nayan has taken Avegen from a single software offering, into a revenue-generating, multi-product company that is currently supporting more than 1 million patients. Previously, Nayan worked for Janssen Healthcare Innovation in the UK, where he led development of the Care4Today Heart Health Solution for US & UK. He has also led multiple deployments of a patient management platform for patients living with HIV & AIDS which has now been launched in multiple countries. Nayan obtained his MBA from London Business School in 2012. Prior to his MBA, Nayan was a trial manager for Johnson & Johnson in the UK and India, and led teams in setting up clinical trials across 18 countries.